Abstract
Oral prednisone (1)might be a convenient, inexpensive alternative to IV methylprednisolone (IVMP) if the bioequivalent dose was known. We compared the total amount of steroid absorbed after 1250 mg oral prednisone vs 1 gram IVMP in 16 patients with multiple sclerosis (MS). At 24 hours, the mean area under the concentration-time curve (AUC), the main component of bioavailability, did not differ between groups (p = 0.122). This suggests that the amount of absorbed corticosteroid is similar after either steroid at these doses.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Oral
-
Adult
-
Anti-Inflammatory Agents / administration & dosage
-
Anti-Inflammatory Agents / pharmacokinetics*
-
Anti-Inflammatory Agents / therapeutic use
-
Area Under Curve
-
Biological Availability
-
Biotransformation
-
Female
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / pharmacokinetics*
-
Immunosuppressive Agents / therapeutic use
-
Infusions, Intravenous
-
Liver / metabolism
-
Male
-
Methylprednisolone / blood
-
Methylprednisolone Hemisuccinate / administration & dosage
-
Methylprednisolone Hemisuccinate / pharmacokinetics*
-
Methylprednisolone Hemisuccinate / therapeutic use
-
Middle Aged
-
Multiple Sclerosis / drug therapy*
-
Multiple Sclerosis / metabolism
-
Multiple Sclerosis, Relapsing-Remitting / drug therapy
-
Multiple Sclerosis, Relapsing-Remitting / metabolism
-
Prednisolone / blood
-
Prednisone / administration & dosage
-
Prednisone / blood
-
Prednisone / pharmacokinetics*
-
Prednisone / therapeutic use
Substances
-
Anti-Inflammatory Agents
-
Immunosuppressive Agents
-
Methylprednisolone Hemisuccinate
-
Prednisolone
-
Prednisone
-
Methylprednisolone